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Hepatitis D virus (HDV) requires the isoprenylated large delta antigen (LDAg) for interaction with hepatitis B surface antigen
(HBsAg) to allow packaging and secretion out of the host cell. Phosphorylated LDAg has been found but, as yet, neither
localization of LDAg within the nucleus nor any other function has been correlated with modification. In this study, we
transfected HuH-7 or HeLa cells with plasmids encoding various lengths of LDAg [designated GFP–LD and GFP–LD(31-214)
for full length and a deletion, respectively] or non-isoprenylated mutants of these [designated GFP–LDM and GFP–LD(31-
214)M] fused to the green fluorescent protein (GFP). These fusion proteins were then characterized and it was found that:
(i) the addition of the GFP did not interfere with the functioning of the full-length or N-terminally deleted LDAgs when
interacting with HBsAg for secretion; (ii) the HDV small antigen (SDAg) together with the GFP–LD, but not the GFP–LD(31-214),
could be cosecreted by HBsAg; and (iii) the GFP–LD, but not the GFP–LD(31-214), exerted a dominant-negative role on HDV
genome replication. Analyses of transiently transfected cells and postmitotic permanent cells revealed the sequential
appearance of GFP–LD in the nucleoplasm, then in the nucleolus, and finally in nuclear speckles (NS). Isoprenylation of LDAg
seems to be important for targeting to and accumulating in the NS, which was evident from the dynamic and static
localization of the non-isoprenylation mutant (GFP–LDM) and the distribution of wild-type (GFP–LD) when treated with an
isoprenylation inhibitor, lovastatin, for more than 48 h. Permanently expressing GFP–LD cells allowed us to show the dynamic
redistribution of dephosphorylated GFP–LD from the nucleolus to the SC-35 containing NS in the presence of dichlororibo-
furanosyl benzimidazole (DRB) and then the translocation back of the GFP–LD to the nucleolus within 2 h after removal of
DRB. Our studies thus suggest that the various versions of the GFP–LD fusion protein, having the same function as their
nonfusion counterparts, can be a powerful tool for the study of the dynamic localization of LDAg when correlated with the
functional modification of this protein. © 2001 Academic Press
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Hepatitis D virus (HDV) was discovered as an agent
associated with severe liver injury in individuals al-
ready infected with hepatitis B virus (HBV) (Rizzeto,
1983). In fact, HDV is a subviral satellite and requires
HBV to supply envelope proteins (HBsAg) for its pack-
aging, secretion, and infection (Ponzetto et al., 1984;
onino et al., 1986). In addition to the HBsAgs, the
irion particle of HDV contains its own genome and
wo isoforms of the HDV encoded antigens (HDAg), the
mall delta antigen (SDAg) and the large delta antigen
LDAg) (for a review see Lai, 1995, and references
herein). The HDV genome comprises a 1.7-kb single-
tranded circular RNA molecule that is approximately
0% self-complementary and forms a highly base-
aired rod-like structure (Chen et al., 1986; Wang et al.,
986; Kos et al., 1986; Makino et al., 1987). The SDAg
s encoded by an open reading frame (ORF) of HDV
nti-genome, contains 195 amino acids, and produces
protein of 24 kDa (Wang et al., 1986; Weiner et al.,a
f
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138988). LDAg, which has a molecular weight of 27,000,
onsists of the same 195 amino acids as the SDAg
ith an additional 19 amino acids at the C-terminus,
hich results from RNA editing and converts an amber
top codon (UAG) to a tryptophan codon (UGG) during
he HDV genome replication cycle (Luo et al., 1990;
asey et al., 1992; Zheng et al., 1992).
Although the two HDAgs share a common 195-
mino-acid sequence, they have opposing biological
unctions in the HDV life cycle. The SDAg is an essen-
ial factor for HDV RNA replication (Kuo et al., 1989),
hile the LDAg is a dominant repressor for replication
Kuo et al., 1989; Chao et al., 1990) and, crucially, is
equired for interaction with HBsAg for packaging and
ecretion (Chang et al., 1991; Ryu et al., 1992). Both
DAgs have been demonstrated to be phosphopro-
eins (Chang et al., 1988; Hwang et al., 1992; Yeh et al.,
996; Bichko et al., 1997; Mu et al., 1999), with phosphor-
lation of SDAg at serine-2, but not of LDAg, being im-
ortant for HDV RNA replication (Yeh et al., 1996). Since
he SDAgs can be phosphorylated at both serine and
hreonine while the LDAg can be phosphorylated only
t serine, this may account for their distinct biological
unctions (Mu et al., 1999). Only the LDAg contains an
139DISTRIBUTION OF GFP-LDAgisoprenylation signal at the C-terminus and mutation
of an isoprenylation site or deletion of 15 amino acids
upstream of the isoprenylation site abolishes the as-
sembly and secretion function of LDAg (Glenn et al.,
1992; Lee et al., 1994, 1995). The SDAg alone cannot
be secreted with HBsAg (Chang et al., 1991; Wang et
al., 1991; Lazinski and Taylor, 1993), but is secreted in
the presence of LDAg, indicating a direct interaction
between SDAg and LDAg (Chang et al., 1992; Lazinski
and Taylor, 1993; Sheu et al., 1996).
Several lines of evidence indicated that the interac-
tion between SDAg and LDAg is important for HDV
replication, assembly, and secretion (Ryu et al., 1992;
Xia and Lai, 1992; Chang et al., 1993; Wang et al.,
1994). The coiled-coil domain at the N-terminus of
HDAgs is required for the interactions that exert acti-
vation or inhibition functions (Lazinski and Taylor,
1993). Other functional domains of HDAgs, such as
RNA-binding, nuclear targeting, and nucleolin-binding
sites, are well mapped and characterized (for a review
see Lai, 1995; Chang et al., 1995; Lee et al., 1998). The
distribution of SDAg and LDAg inside of transfected
cells, with or without the presence of the whole HDV
genome, has been studied by immunofluorescence to
reveal the pattern in the nucleoplasm, the nucleolus,
the SC35-containing speckles, and the Golgi complex
(Xia et al., 1992; Wu et al., 1992; Chang et al., 1992;
Bichko and Taylor, 1996). By using anti-farnesyl anti-
body, the isoprenylated LDAg can be localized in the
nucleolus (Lin et al., 1999). However, correlation of the
distribution of HDAgs with their modification and func-
tion remains largely unknown.
In the past few years, many studies have shown that
the green fluorescent protein (GFP) from jellyfish is a
popular tool for localization of a specific protein dis-
tribution inside cells when the GFP is fused with that
particular protein (Misteli and Spector, 1997; White
and Stelzer, 1999). Many GFP–fusion proteins are
found to retain all the functions of their authentic
proteins and are nontoxic to cells. Thus GFP fusion
can be used for the study of dynamic change inside
cells as was done with protein kinase C and coilin
(Sakai et al., 1997; Boudonck et al., 1999). In this study,
we fused a full-length LDAg with GFP (GFP–LD) and
created three mutants, including the non-isoprenyla-
tion mutant (GFP–LDM), deletion mutant [GFP–LD(31-
214)], and double mutant of the deletion and non-
isoprenylation form [GFP–LD(31-214)M]. This system
allowed us to detect the dynamic distribution of LDAgs
inside the nucleus when LDAgs are isoprenylated/
non-isoprenylated or phosphorylated/dephosphory-
lated, and to our knowledge, this is the first report
showing how the distribution of LDAg in various loca-
tions correlates with its modification.RESULTS
Various forms of LDAg fused with GFP produce
different nuclear distribution patterns
To visualize a dynamic distribution of LDAg in living
cells, we constructed plasmids of the wild-type and an
N-terminally truncated mutant (deleted for amino acids 1
to 30) of LDAg fusing to the C-terminus of GFP and
designated pGFP–LD and pGFP–LD(31-214), respec-
tively. Two other closely related plasmids, pGFP–LDM
and pGFP–LD(31-214)M, were also created by mutation
of the isoprenylation site of pGFP–LD and pGFP–LD(31-
214). The distribution of these GFP–fusion proteins was
examined during transient transfection of these plasmids
into HuH-7 or HeLa cells for 3 days posttransfection and
on permanent expression in HeLa cells. A unique distri-
bution pattern was observed for each fusion protein,
either during transient transfection or on permanent ex-
pression. The unique distribution pattern for each fusion
protein was similar in cells of both hepatic (HuH-7) and
nonhepatic (HeLa) origin.
Four different permanently transfected HeLa cells
were obtained by transfection of pGFP–LD, pGFP–LDM,
pGFP–LD(31-214), and pGFP–LD(31-214)M. We corre-
lated the distribution pattern of the GFP–fusion proteins
with their location in the cells by staining with anti-
nucleolin, a prominent marker for the nucleolus, and the
DNA dye Hoechst 33258. The GFP–LD in HeLa cells
appeared in both the nucleolus and the nuclear speckles
(NS) (Figs. 1A, 1B, and 1C). The latter varied in size (0.1–3
mm) and number (3–30) (Fig. 1A). The colocalization of
GFP–LD and nucleolin (Fig. 1C) was similar to that of
authentic LDAg and nucleolin (data not shown, Lee et al.,
1998). An even distribution pattern of GFP–LD, instead of
a prominent nucleolus and NS pattern, was observed in
a dividing cell (the left center cell shown in Fig. 1A). In
cells expressing the non-isoprenylation fusion protein
GFP–LDM, the green fluorescent signals (Fig. 1E) were
present mostly in the nucleolus (Figs. 1F and 1G). Occa-
sionally, the GFP–LDM protein was also observed in the
nuclear speckles, which were larger and fewer than 5 in
number (Fig. 1E) compared to the wild-type GFP–LD (Fig.
1A). Unlike the full-length GFP–LD/GFP–LDM expression
patterns, the patterns of distribution of GFP–LD(31-214)
and GFP–LD(31-214)M were very similar, with an even
distribution in the nucleoplasm including the nucleolus
(Figs. 1I and 1M). Interestingly, the distribution of nucleo-
lin in some stably expressing cells was changed from
an oval-rounded form into an irregular form (Figs. 1J
and 1N).
N-terminal deletion mutants of LDAg have a lower
density than full-length versions in the sucrose
gradientTo know whether the different distribution pattern of
LDAg fusion proteins was due to an inability to form
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140 SHIH AND LOFIG. 1. Fluorescence pattern of various forms of LDAg fused with the green fluorescent protein (GFP) in permanently transfected HeLa cells. (A–D)
FP–LD; (E–H) GFP–LDM; (I–L) GFP–LD(31-214); (M–P) GFP–LD(31-214)M. Pictures in the first (leftmost) column were obtained using a fluorescence
icroscope with a FITC filter and show the GFP pattern (A, E, I, and M). The pictures in the second column show cells stained with anti-nucleolin
ntibody and a secondary antibody conjugated with rhodamine (B, F, J, and N). The third column shows the merged pictures from the first and second
olumns (C, G, K, and O). The yellow color indicates the colocalization of GFP–fusion protein with nucleolin. The fourth column shows cells stained
ith DNA dye to outline the morphology of the nucleus (D, H, L, and P). A dividing cell is indicated by an arrow. All pictures were taken at the same
agnification as indicated by the 10-mm bar in P.
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141DISTRIBUTION OF GFP-LDAgmultimers or an inability to interact with different cellular
factors that resulted in forming complexes of various
densities, we performed sucrose density analysis. The
nuclear extracts from permanently expressing HeLa
cells were subjected to centrifugation on a 10–50% su-
crose gradient. The presence of GFP–fusion protein in
each density fraction was analyzed by SDS–PAGE fol-
lowed by Western blot detection using anti-HDAg anti-
body. For a comparison, some blots were also probed
with anti-nucleolin. As is characteristic of nucleolin, it
was widely distributed in various density fractions (frac-
tions 3 to 18), although there were two peaks, one at
lower density (fractions 3–8) and other at a higher den-
sity (fractions 14–18) (Fig. 2A). The broad distribution of
nucleolin was similar in the coexpression with GFP–LD
or with authentic LDAg (Huang et al., 2001). In contrast,
he GFP–LD with an expected molecular mass of 57 kDa
ad a less broad distribution, from fractions 7 to 18 (1.35
o 1.80 g/ml), and was concentrated mostly in fractions 8
nd 9 (1.40 to 1.44 g/ml) (Fig. 2B). Nevertheless, the
oexistence of nucleolin and GFP–LD in the lower part of
he gradient (fractions 14–18) suggested that GFP–LD
nd nucleolin might form a complex or be associated
Lee et al., 1998) and present in the nucleolus as shown
n Fig. 1C. The GFP–LDM with a molecular weight similar
o that of GFP–LD showed a slightly different distribution
attern, being distributed from fractions 9 to 18 (1.44 to
.80 g/ml) with the highest concentration in fraction 9
Fig. 2C). Whether these minor differences between
FP–LD and GFP–LDM were due to their prenylation
tate or due to an association with some cellular factors
s unclear. GFP–LD(31-214) and GFP–LD(31-214)M, which
as a molecular mass of around 54 kDa, showed similar
istributions between fractions 3 and 8 (1.20 to 1.30 g/ml)
Figs. 2D and 2E). The reason that both deletion proteins
ere not present in the heavier fractions, as were their
ull-length counterparts, may be truncation of these pro-
eins’ coiled-coil domain. Although the density of the two
eletion mutants was lower than that of the full-length
ersions, the deletion mutants could also self-associate
r bind different cellular factors, since their density was
quivalent to a molecular mass of around 150 kDa, sig-
ificantly heavier than their expected molecular mass of
4 kDa.
FP fusion of the full-length or N-terminal deletion of
DAg in an isoprenylated form is able to be
osecreted with HBsAg
Previously, the LDAg has been demonstrated to be
acked and secreted by HBsAg (Wang et al., 1991; Chen
t al., 1992). To test whether the GFP–fusion proteins still
etain such biological activity, we cotransfected plasmids
xpressing the various fusion proteins with an HBsAg
xpression plasmid. Medium from 3 and 6 days post-ransfection was collected and analyzed for the presence
f GFP–fusion protein. Western blot analysis showed that
oth GFP–LD and GFP–LD(31-214) were secreted by the
BsAg as authentic LDAgs (Fig. 3B, lanes 2, 4, and 6),
ut neither of the nonprenylation mutants, GFP–LDM
nd GFP–LD(31-214)M, were secreted (Fig. 3B, lanes
and 7). Intracellular analyses showed that GFP–
DM and GFP–LD(31-214)M were indeed expressed
nside the transfected cells (Fig. 3A, lanes 5 and 7).
aking these results together, we concluded that the
ddition of GFP prior to that of the LDAg did not inter-
ere with its biological function of secretion by HBsAg.
his is consistent with previous reports that the coiled-
oil domain is not required for LDAg secretion while
soprenylation is so required (Chen et al., 1992; Sheu et
al., 1996).
GFP–LD(31-214) loses the capability to interact with
SDAg for secretion with HBsAg
It has been shown that the SDAg alone cannot be
packed into HBsAg particles except in the presence of
LDAg (Wang et al., 1991; Sheu et al., 1996). To examine
whether the secretable GFP–LD and GFP–LD(31-214)
still have the ability to cosecrete SDAg, we cotransfected
plasmids expressing the SDAg (pMTSD) and the GF-
P–LD or GFP–LD(31-214) [pGFP–LD or pGFP–LD(31-214)]
with the plasmid expressing the HBsAg (pMTS). Western
analyses showed that the SDAg coexisted with various
forms of LDAgs inside the transfected cells (Fig. 4A,
lanes 3 to 5). However, the collected media showed that
wild-type GFP–LD but not the N-terminally truncated mu-
tant GFP–LD(31-214) can cosecrete SDAg (Fig. 4B, lane 5
vs lane 4). It has been demonstrated that the N-terminal
leucine zipper motif (amino acids 29–56) of HDAg partic-
ipates in the interaction of LDAg and SDAg during virion
assembly (Lai, 1995). The current data suggest that the
N-terminal 30-amino-acid deletion may disrupt the struc-
ture of the leucine zipper motif and the result is the loss
of interaction between GFP–LD(31-214) and SDAg during
HBsAg particle assembly (Moraleda et al., 1999).
HDV RNA replication is inhibited by the full-length
GFP–fusion proteins but not the N-terminal deletion
mutants
To determine whether the GFP–LDAg fusion proteins
exhibit the trans-dominant inhibition of authentic LDAg
on HDV RNA replication, we transfected pCMVDag2, a
CMV promoter driving replication-competent dimer of
1.7-kb HDV cDNA, into the stable cells that constantly
express GFP–LD, GFP–LDM, GFP–LD(31-214), or GFP–
LD(31-214)M. After 6 days posttransfection, cells were
lysed and HDV RNA was analyzed by Northern blot. As
shown in Fig. 5A, HDV RNA replication was almost com-
pletely inhibited in the GFP–LD and GFP–LDM expres-
kDa a
rd mar
142 SHIH AND LOsion cells (lanes 6 and 7), but not in the GFP–LD(31-214)
and GFP–LD(31-214)M cells (lanes 4 and 5). The inhibi-
tion results obtained for full-length LDAgs were sup-
ported by the evidence from loading an internal control
with an equal amount of RNA at a similar transfection
efficiency and the resultant production of HDAg (Figs. 5B,
5C, and 5D). These data suggest that the deletion of
N-terminal LDAg has resulted in loss of an essential
domain for the inhibition of HDV RNA replication and the
FIG. 2. Sucrose density gradient analysis of various GFP–LDAg fusi
subjected to a 10 to 50% discontinuous sucrose gradient. The gradien
nucleolin from the GFP–LD cells was analyzed by anti-nucleolin antibod
anti-HDAg antibody and are shown in (B) GFP–LD, (C) GFP–LDM, (D)
fractions from the top to the bottom of the gradient. The catalase is 220
and are located in fractions 7 and 10, respectively. The protein standaLDAg fusion with GFP does not mask the conformation
that causes trans-inhibition. wAn inhibitor of isoprenylation decreases the nuclear
speckle distribution of GFP–LDAg
Since the nuclear distribution between GFP–LD and
GFP–LDM differed in the number of NS (Fig. 1A vs 1E),
we attempted to verify whether isoprenylation was a
factor in LDAg targeting to and accumulating in NS. We
treated both the GFP–LD and the GFP–LDM permanently
expressing cells with a mevalonate synthesis inhibitor,
eins. The nuclear extracts of permanent transfection HeLa cells were
fractionated into 18 tubes from the top to bottom. The distribution of
he GFP–LDAgs from four different stable cell lines were detected using
D(31-214), and (E) GFP–LD(31-214)M. The number (1–18) indicates the
nd thyroglobulin is 660 kDa; these were used as fractionation markers
kers for SDS–PAGE are indicated to the left of each panel.on prot
ts were
y (A). T
GFP–Llovastatin (Sinensky et al., 1990; Ivessa et al., 1997),
hich results in the inhibition of isoprenylation. After 48 h
ze of e
ther tr
), pGFP
143DISTRIBUTION OF GFP-LDAgof lovastatin treatment, the nucleoplasmic pattern of
GFP–LD changed, with the numbers of NS being re-
duced compared with untreated cells or cells treated for
24 to 36 h (Fig. 6D vs Figs. 6A, 6B, and 6C). Almost no
speckle pattern could be observed when the GFP–LD
cells were treated with lovastatin for 60 h (Fig. 6E) com-
pared with the GFP–LD cells incubated in the control
medium for 60 h (Fig. 6F). In contrast, the distribution
pattern for GFP–LDM was similar in both treated and
untreated cells, where it appeared in the nucleolus with
little or no speckle pattern (data not shown). These re-
sults suggest that the isoprenylation of GFP–LD is a
modification that may cause the protein to localize to
the NS.
Sequential distribution and accumulation of GFP–LD
observed in various sites of the nucleus
FIG. 3. Western blot analysis of the secretion capability of the GFP
cotransfected with an HBsAg expressing plasmid into human hepatoma
proteins were analyzed using anti-HDAg antibodies. The predicted si
markers are indicated on the left. Lane 1 shows a mock transfection. O
as follows: pMTSD (lane 2), pMTLD (lane 3), pGFP–LD(31-214) (lane 4The advantage of using a GFP–fusion protein is that
the dynamic location of the protein can be followed inliving cells. It is possible for us to trace the sequential
distribution of GFP–LD through the cell. After 8 h post-
transfection, the GFP–LD was observed inside the nu-
cleus, appearing with an even distribution pattern (Fig.
7A). Thereafter, up to 20 h posttransfection, the GFP–LD
appeared in the nucleolus and remained in the nucleo-
plasm (Fig. 7A). After 36 h posttransfection, although the
distribution of GFP–LD was not synchronized in every
transfected cell, the speckle pattern of LDAg became
obvious (Fig. 7A). A prominent speckle and nucleolus
distribution of GFP–LD were easily observed after 48 h
posttransfection (Fig. 7A) and the pattern was similar to
that seen in the permanently expressing cells (Fig. 1A).
The redistribution of GFP–LD was also detected in the
permanently expressing cells, which were at a point in
the cell cycle right after the mitosis stage. As shown in
Fig. 7B, the sequential distribution of GFP–LD seemed to
fusion protein with HBsAg. Various plasmids encoding HDAg were
HuH-7. Six days posttransfection, the intracellular (A) and secretion (B)
ach LDAg protein is indicated on the right and the protein standard
ansfected plasmids, in addition to the plasmid expressing HBsAg, are
–LD(31-214)M (lane 5), pGFP–LD (lane 6), and pGFP–LDM (lane 7).–LDAg
cells,be nucleoplasm 3 nucleolus 3 NS. Combining the
results of the transient transfection and the postmitosis
SD (la
a
144 SHIH AND LOof permanent cells suggested that the specific localiza-
tion of GFP–LD in various structures may be dependent
on its conformation when associated with a particular
nuclear protein.
Redistribution of GFP–LD between the nucleolus and
SC-35 containing NS by DRB treatment
Previously, the LDAg has been demonstrated to show
a 50% reduction in phosphorylation in the presence of
the casein kinase II (CKII) inhibitor, dichlororibofuranosyl
benzimidazole (DRB) (Yeh et al., 1996). We were therefore
interested to know whether the distribution of GFP–LD
would be changed when cells were treated with DRB. As
shown in Fig. 8, after 1 h of treatment with DRB, the
GFP–LD in the nucleolus was concentrating in a few
spots and the number of NS had increased. After 2 h,
FIG. 4. Western blot analysis of the cosecretion of SDAg with various
of LDAg were cotransfected with pMTS expressing HBsAg and pMTS
fection, the intracellular (A) and secretion (B) proteins were analyzed us
on the right and the protein standard markers are indicated on the le
plasmids, other plasmids used in each transfection are as follows: pMT
nd pMTSD 1 pGFP–LD (lane 5).GFP–LD was mainly in NS and very little remained in the
nucleolus (Fig. 8C). When DRB was removed for 1 h,GFP–LD remained largely in NS (Fig. 8D). However, 2 h
postremoval of DRB, the GFP–LD relocated back to the
nucleolus (Fig. 8E). The most interesting feature is that
each cell retained the same number of nucleoli as before
DRB treatment. In order to identify the nature of the NS
that the GFP–LD targets to, we stained with anti-SC 35
antibody cells treated with or without DRB. As shown in
Fig. 9, in untreated cells, GFP–LD was in the nucleolus
and in small NS (Fig. 9A) and only a small portion of
GFP–LD (,1%) was colocalized with SC-35 in the NS
(Fig. 9C). However, after cells were treated with DRB for
2 h, GFP–LD was present in NS only and 90% of the
GFP–LD costained with SC-35 (Fig. 9G).
DISCUSSION
The role and function of LDAg in the HDV replication
DAg fusion proteins and HBsAg. Plasmids encoding the various forms
essing SDAg into human hepatoma cells, HuH-7. Six days posttrans-
ti-HDAg antibody. The predicted size of each LDAg protein is indicated
e 1 shows a mock transfection. In addition to the transfected pMTS
ne 2), pMTSD 1 pMTLD (lane 3), pMTSD 1 pGFP–LD(31-214) (lane 4),GFP–L
D expr
ing an
ft. Lancycle have been largely explored in the past decade,
including its subdomain, modification, and distribution
H
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145DISTRIBUTION OF GFP-LDAginside of the nucleus (Kuo et al., 1989; Chao et al., 1990;
Chang et al., 1991, 1995; Ryu et al., 1992; Glenn et al.,
1992; Lee et al., 1994; Yeh et al., 1996; Wu et al., 1992; Lin
et al., 1999). Very recently, LDAg location at the promy-
elocytic leukemia protein (PML)-containing speckles
with the HDV anti-genome has well been studied (Bell et
al., 2000). However, the following events, (i) location of
LDAg when inhibition of HDV RNA replication occurs, (ii)
the location of assembly with SDAg and the HDV ge-
nome to form RNP, and (iii) the interaction with HBsAg to
FIG. 5. Inhibition of HDV genome replication in HeLa cells expressin
DV RNA genome. (B) Northern blot analysis of cellular G3PDH expre
ndicated transfection efficiency. (D) Western blot analysis of the intrac
ndicated to the left of each panel. Protein standard markers are sho
otransfection of pCMVDag2 and pMTSD into HeLa cells. Lane 3: cotr
otransfection of pCMVDag2 and pMT into HeLa cells constantly expr
nd GFP–LDM (lane 7).form viral particles, are less well defined. By using the
powerful tool of GFP in this study, we are able to dem-onstrate the translocation of LDAg between the nucleo-
lus and various nuclear speckles when it is modified in
different ways, either by isoprenylation or by phosphor-
ylation. In addition, we have demonstrated that the ad-
dition of GFP to the N-terminal of LDAg does not alter any
of the known functions of LDAg. Although an ectopic
addition (Ras) on LDAg has been shown not to interfere
with LDAg secretion (Lee et al., 1995), the GFP–LD in this
study has the longest addition as yet that retains all three
different functions of LDAg.
us GFP–fusion proteins. (A) Northern blot analysis of the intracellular
(C) Southern blot analysis of transfected plasmid, pCMVDag2, which
HDAg. The predicted migration positions of RNA, DNA, or protein are
the right of D. Lane 1 is a mock transfection of HeLa. Lane 2: the
ion of pCMVDag2 and pMTLD into HeLa cells. Lanes 4 to 7 show the
GFP–LD(31-214) (lane 4), GFP–LD(31-214)M (lane 5), GFP–LD (lane 6),g vario
ssion.
ellular
wn on
ansfectAnother novel finding in this study is the linking to-
gether of the distribution, biochemistry, and function of
g
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146 SHIH AND LOLDAg. Although the importance of the coiled-coil domain
at the N-terminal LDAg for oligomerization has been
demonstrated (Xia and Lai, 1992; Wang and Lemon, 1993;
Zuccola et al., 1998), we are the first to use a sucrose
gradient to separate the complex containing LDAg into
various densities and to show that the N-terminally trun-
cated protein forms a lower density complex (Figs. 2C
and 2D). This can be interpreted as showing that the
coiled-coil domain is important not only for LDAg self-
oligomerization but that it also plays a part in the inter-
action with factors that are present in the nucleolus, such
FIG. 6. Fluorescence pattern of GFP–LD distribution after lovastatin tr
lovastatin for (A) 0, (B) 24, (C) 36, (D) 48, or (E) 60 h. Cells were incubas nucleolin (Figs. 1C and 1G vs 1K and 1O). Very
recently, Grosset et al. (2000) used the sucrose density
t
nradient method to demonstrate that five proteins (Unr,
ABP, PAIP-1, NSAP1, and hnRNP D) exist as a complex.
e thus suggest that the sucrose density separation
ethod is an alternative choice, other than the method of
east two-hybrid and coimmunoprecipitation, to search
or HDAg-associated proteins.
In addition to the previous study showing the direct
inding of HDAg and nucleolin (Lee et al., 1998), the
urrent study indicated that the GFP–LD and GFP–LDM
ight form various density complexes with the nucleolin
nd present mainly in the nucleolus (Figs. 1 and 2). Since
t. The permanently expressing GFP–LD cells were treated with 50 mM
a control buffer for 60 h (F). The scale bar represents 10 mm.he GFP–LD(31-214) and GFP–LD(31-214)M appear in the
ucleoplasm homogeneously (Fig. 1) and they lost the
itotic di
10 mm
147DISTRIBUTION OF GFP-LDAgability to inhibit HDV RNA replication (Fig. 5A), the nucle-
olus is thus suggested to be the site for HDV replication.
This suggestion is supported by the finding that HDV
anti-genome synthesis is insensitive to a-amanitin (Mo-
FIG. 7. Redistribution of GFP–LD. (A) Posttransfection fluorescence
Times posttransfection are 8, 20, 36, and 48 h as indicated. (B) Postm
postmitosis are 0, 3, 6, and 9 h as indicated. The scale bar representsdahl et al., 2000) and that SDAg associates with nucleolin
(Lee et al., 1998). The current data also suggest thatisoprenylation may not be required for trans-inhibitory
activity (Fig. 5A, lane 6), which does not agree with
previous observations (Hwang and Lai, 1994). Since dif-
ferent versions of non-prenylated LDAg could behave
of GFP–LD after transient transfection of pGFP–LD into HeLa cells.
stribution of GFP–LD in permanently expressing HeLa cells. Times of
.patterndifferently depending on their conformations (Hwang and
Lai, 1994), the trans-inhibitory domain of GFP–LDM fu-
i pears i
r d with
148 SHIH AND LOsion may remain as exposed as that of LDAg and GFP–
LD, allowing interaction.
One great advantage that GFP offers is the study of the
dynamic distribution of a fusion protein of interest in
living cells under different physiological conditions. In
this study, we treated GFP–LD cells with lovastatin and
DRB, although both have a pleiotropic effect on cell
metabolism, to demonstrate the dynamic distribution of
FIG. 8. Fluorescence pattern of GFP–LD after treatment with DRB an
n the nucleolus (0 h, A). After 1 or 2 h of DRB treatment, the GFP–LD ap
emoval and its replacement with fresh medium (D and E are indicateGFP–LD (Figs. 6 and 8). One might argue that the dy-
namic distribution of GFP–LD was not directly due toGFP–LD modification. However, comparing the distribu-
tion pattern of lovastatin treatment of GFP–LD express-
ing cells with the GFP–LDM expressing cells, we sug-
gest that isoprenylation is important for LDAg targeting to
the NS with PML. Since the same concentration of DRB
(100 mM) was used in this study as in the previous study
(Yeh et al., 1996), translocation of GFP–LD to the SC-35
containing NS (Fig. 9) is very likely due to the dephos-
oval of the DRB. Before DRB treatment, the GFP–LD is located mainly
n a speckled form (B and C). The nucleolus pattern resumes after DRB
R 1 h and R 2 h). The scale bar represents 10 mm.d remphorylation of GFP–LD. The coexistence of HDAg with
PML and SC-35 in NS has been previously reported and
ted ce
0 mm.
149DISTRIBUTION OF GFP-LDAgthis was used to suggest that the SC-35 NS are the site
FIG. 9. Fluorescence pattern of GFP–LD and SC-35 in GFP–LD cells
pattern; (B and F) SC 35 pattern; (C and G) merged pictures of A 1 B a
a few speckled spots display GFP–LD coexisting with SC-35 in untrea
(shown in yellow) in the DRB-treated cells. The scale bar represents 1for HDV replication (Bichko and Taylor, 1996). Although
the mechanism and function of the shuttling between thetwo different types of NS and the nucleolus are not
with (the right column) or without (the left column) DRB. (A and E) GFP
F; and (D and H) DNA staining. The merged pictures show that only
lls while 90% of speckles show colocalization of GFP–LD with SC-35treated
nd E 1known, this study is the first to demonstrate that LDAg
can be located in different compartments when it is
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150 SHIH AND LOmodified differently. However, the current observation is
inconsistent with previous findings that the LDAg can be
detected only in the nucleolus when anti-farnesyl anti-
body staining is used (Lin et al., 1999). The discrepancy
ould be due to the insensitivity of the anti-farnesyl
ntibody stain as a method of detecting LDAg located in
he speckle when the amount of LDAg is small. Alterna-
ively, when the LDAg is transported to the speckle, the
onformation of LDAg may be changed such that the
soprenylation site is hidden and can no longer be
tained. These two hypotheses were based on the neg-
tive results of anti-farnesyl antibody staining on the
FP–LD expressing cells (data not shown). Neverthe-
ess, both experiments demonstrate that prenylated
DAg can be present inside the nucleus.
In summary, by using GFP–fusion protein of HDV
DAg, in this study we have shown that the known
iological functions of LDAg are not interfered with by
usion with GFP. This is also the first demonstration that
he isoprenylation of LDAg can target it to the PML-
ontaining NS and that dephosphorylation of LDAg is
mportant for targeting to the SC-35 NS. Whether the
equential accumulation of GFP–LD is correlated with
he modification and functions of LDAg needs further
tudy. Nevertheless, different versions of GFP–fusion
roteins can be used for dynamic studies in the future. It
ill be interesting to know whether or not coexpression
f HBsAg and GFP–LD will change the general distribu-
ion pattern of GFP–LD.
MATERIALS AND METHODS
lasmid construction
The eukaryotic expression vector pEGFP-C3, which
ontains the jellyfish gene of GFP, was obtained from
lontech Laboratories, Inc. (Palo Alto, CA). The coding
egion of full-length HDV LDAg was first generated by
CR using a primer containing a Kozak sequence and
loned into pGEMT to give pGEMT-L. The full-length HDV
DAg fragment was then excised from pGEMT-L and
nserted into the BglII and EcoRI sites of pEGFP-C3,
esulting in pGFP–LD. The pGFP–LDM plasmid contain-
ng a single mutation at the C-terminal cysteine of LDAg
as generated in a similar manner except that a primer
ontaining a mutation of Cys210 was used. Plasmids
GFP–LD(31-214) and pGFP–LD(31-214)M were con-
tructed by inserting the HDV XhoI–EcoRI DNA frag-
ents from the previously established pGEM3(2)-L and
GEMLm (Hu et al., 1996) into pEGFP-C3. The plasmid of
CMVDag2 was derived from pSVL-d2g (Yeh et al., 1996)
in which a CMV promoter replaces the SV40 T antigen
promoter to drive the dimer of 1.7-kb HDV cDNA and to
produce an anti-genome of HDV RNA. Other non-GFP-
containing plasmids, including pMTS, pMTLD, and
pMTSD, were described previously (Sheu and Lo, 1992;
Sheu et al., 1996).
c
bCell culture and transfection of HuH-7 and HeLa cells
Two human cell lines were used for plasmid transfec-
tion in this study. One is a well-differentiated human
hepatoma cell line, HuH-7 (Nakabayashi et al., 1982), and
he other is epitheloid carcinoma cell line, HeLa (Eagle,
955). Both cells were cultured in Dulbecco’s modified
agle’s medium supplemented with 10% fetal bovine
erum, penicillin (100 IU/ml), streptomycin (100 mg/ml),
Fungizone (50 mg/ml), and 2 mM L-glutamine and grown
at 37°C under 5% CO2. Plasmids in a supercoiled form
were obtained using the Qiagen Plasmid Maxi Kit
(Hilden, Germany) and then used for transfection. For the
packaging study, HuH-7 cells at 60% confluence in a
10-cm petri dish were cotransfected with 10 mg of plas-
id pMTS, an HBsAg expression plasmid, and 10 mg of
a plasmid encoding the wild-type LDAg, GFP–LD, GFP–
LDM, GFP–LD(31-214), or GFP–LD(31-214)M by the cal-
cium phosphate–DNA precipitation method (Graham and
van der Eb, 1973). For generation of permanently ex-
pressing cell lines, the transfected HeLa cells were
scraped off, reseeded to 10-cm plates, and selected with
G418 (1 mg/ml) (Gibco BRL). Single colonies were then
generated by limited dilution cloning.
Fluorescence microscopy
Transiently or permanently transfected cells that ex-
press GFP–LD or other variants were cultured on 22 3
22 mm coverslips. Cells were fixed with 4% paraformal-
dehyde/PBS for 30 min at room temperature, stained first
with anti-nucleolin antibody (Chen et al., 1991), and then
stained with the secondary goat-anti-mouse antibody
conjugated with rhodamine. Thereafter cells were
stained with Hoechst 33258, mounted on glass slides
with mounting solution, and visualized with a fluores-
cence microscope (Olympus B-Max 60) or a confocal
microscope (Leitz). For visualization of the dynamic dis-
tribution of the GFP–fusion proteins in transiently trans-
fected cells or permanent cells treated with drugs (50
mM lovastain or 100 mM DRB), cells were examined
sing the Olympus B-Max 60 microscope and photo-
raphed.
uclear extract and sucrose gradient
Permanently transfected cells were washed twice with
BS, scraped off from the culture dish, and collected by
entrifugation. Cells were resuspended in 0.5 ml PBS
nd then lysed by the addition of 0.5 ml of 2% Triton
-100/PBS on ice. After 1 min, the cell lysates were
entrifuged at 3000 rpm for 1 min to obtain the insoluble
uclear pellets, which were resuspended into 0.5 ml PBS
nd homogenized by sonication. The sonicated nuclear
xtracts (0.8 ml) were layered over a 10–50% (w/v) dis-
ontinuous sucrose gradient made up of sucrose in NET
uffer [150 mM NaCl, 0.5 mM EDTA, 50 mM Tris–Cl (pH
a
m
c
f
i
151DISTRIBUTION OF GFP-LDAg7.5)] and then subjected to centrifugation at 38,000 rpm in
an SW41 rotor (Beckman) for 16 h at 4°C. The gradients
were fractionated into 18 0.6-ml samples and the density
of each fraction was determined from the refractive index
using a refractometer.
Western blotting
Protein samples were separated by SDS–PAGE (Lae-
mmli, 1970) and electrotransferred onto PVDF mem-
branes (Immuobilon-P, Millipore) as described by Towbin
et al. (1979). The membranes were first incubated with
5% nonfat milk and then with human anti-HDAg sera (Yeh
et al., 1996) or anti-nucleolin (Chen et al., 1991) as alter-
native primary antibodies and then with horseradish per-
oxidase-conjugated anti-human antibody as the second-
ary antibody. The blot was detected by enhanced chemi-
luminescence (ECL Kit, Amersham Japan, Tokyo, Japan)
or developed using 4-choloro-1-naphtol as the substrate.
Northern blotting
Total RNA was extracted from transfected HeLa cells
using the REnol C&T kit (PROtech Technologies, Inc.)
following the protocol from the supplier. RNA samples
(20 mg) were electrophoresed on a 1% RNA agarose gel
nd then transferred to nylon membrane by the capillary
ethod (Sambrook et al., 1989). The membrane was
rosslinked using the UV Stratalinker 2400 (Stratagene),
ollowed by prehybridization with Ultrasensitive Hybrid-
zation buffer (Ambion) and hybridization with 32P-labeled
HDV-specific DNA probe. The filter was finally exposed
to the Molecular Dynamic Storage Phosphor Screen.
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